BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...of clinical development. Yu was co-founder and VP of corporate strategy, finance and operations at Qpex Biopharma Inc....
BioCentury | Nov 21, 2019
Company News

Brii continues to grow infectious disease pipeline via deal with start-up AN2

...Brii Bio Partnered with Microbiome Start-up Artizan" ). And in October, Brii gained rights from QPex Biopharma Inc....
BioCentury | Oct 26, 2019
Company News

Oct. 25 Company Quick Takes: Astellas gets European approval for AML therapy; plus Acorda, Amgen, Illumina-PacBio and Qpex-Brii

...a final report is due in December. Brii gains China rights to Qpex anti-infective therapies Qpex Biopharma Inc....
...gilteritinib (ASP2215) Repatha (Brand), AMG 145 (Compound #), evolocumab (Generic), Repatha (Other) Illumina Inc. Pacific Biosciences of California Inc. Qpex Biopharma Inc. Astellas...
BioCentury | Oct 26, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc....
...Qpex’s A round has two tranches; details are not disclosed. Qpex Biopharma Inc., San Diego, Calif. Paul Bonanos Qpex Biopharma Inc. The...
BioCentury | Oct 26, 2018
Finance

Rempex remix

...New Enterprise Associates led Qpex Biopharma Inc.’s $33 million A round in hope that the management team will...
...Fund. Adams Street was also an investor in Mpex and Rempex. Virginia Li, Assistant Editor New Enterprise Associates Qpex Biopharma Inc. The...
BioCentury | Oct 22, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc....
Items per page:
1 - 6 of 6
BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...of clinical development. Yu was co-founder and VP of corporate strategy, finance and operations at Qpex Biopharma Inc....
BioCentury | Nov 21, 2019
Company News

Brii continues to grow infectious disease pipeline via deal with start-up AN2

...Brii Bio Partnered with Microbiome Start-up Artizan" ). And in October, Brii gained rights from QPex Biopharma Inc....
BioCentury | Oct 26, 2019
Company News

Oct. 25 Company Quick Takes: Astellas gets European approval for AML therapy; plus Acorda, Amgen, Illumina-PacBio and Qpex-Brii

...a final report is due in December. Brii gains China rights to Qpex anti-infective therapies Qpex Biopharma Inc....
...gilteritinib (ASP2215) Repatha (Brand), AMG 145 (Compound #), evolocumab (Generic), Repatha (Other) Illumina Inc. Pacific Biosciences of California Inc. Qpex Biopharma Inc. Astellas...
BioCentury | Oct 26, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc....
...Qpex’s A round has two tranches; details are not disclosed. Qpex Biopharma Inc., San Diego, Calif. Paul Bonanos Qpex Biopharma Inc. The...
BioCentury | Oct 26, 2018
Finance

Rempex remix

...New Enterprise Associates led Qpex Biopharma Inc.’s $33 million A round in hope that the management team will...
...Fund. Adams Street was also an investor in Mpex and Rempex. Virginia Li, Assistant Editor New Enterprise Associates Qpex Biopharma Inc. The...
BioCentury | Oct 22, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc....
Items per page:
1 - 6 of 6